Notable Labs Ltd

Notable Labs Ltd

NTBL

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.39M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Notable Labs LtdNotable Labs Ltd0--174%-0.2
$-0.03

Current Fair Value

111.7% downside

Overvalued by 111.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.39 Million
Enterprise Value$97,590.00
Dividend Yield$- (-)
Earnings per Share$-5.03
Beta-2.36
Outstanding Shares9,455,751

Return

Return on Equity-173.92%ROE
Return on Assets-113.58%
Return on Invested Capital-152.24%

Valuation & Multiples

P/E Ratio-0.05P/E Ratio
PEG-0.01PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue32.53
Enterprise Value to EBIT-0.01
Enterprise Value to Net Income-1
Total Debt to Enterprise18.39
Debt to Equity0.25Debt to Equity

Revenue Sources

No data

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Notable Labs Inc

17 employees
CEO: Dror Harats

vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.